NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

Start Free »

SKIN | NASDAQ

$11.56 $0.75 | 6.94%

TREND SIGNAL: Signal available — unlock to view

|2026-10-12

Add to favoritesFavorite

Company Overview:

Market Cap: $1.50B

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $0.55 - $13.32

5.9 Year SKIN Performance Metrics:

Total Return (with DRIP): 6.6% (1.10% CAGR)

Total Return (no DRIP): 6.6% (1.10% CAGR)

Share Price: 6.6% (1.10% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $10,664

Total Return $ (with DRIP): $664

SKIN Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

SKIN Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

SKIN Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

SKIN - Revenue

SKIN Revenue CAGR:1Y: -7.77%2Y: -10.78%5Y: 1.63%10Y: 0.00%

SKIN - Earnings Per Share (EPS)

SKIN EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

SKIN - Net Income

🔓 See the full chart40% off right now · 7-day free trial

SKIN Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

SKIN - EBITDA

🔓 See the full chart40% off right now · 7-day free trial

SKIN EBITDA CAGR:1Y: -54.03%2Y: 7.62%5Y: 0.00%10Y: 0.00%

SKIN - Free Cash Flow

🔓 See the full chart40% off right now · 7-day free trial

SKIN Free Cash Flow CAGR:1Y: -86.41%2Y: -40.66%5Y: 0.00%10Y: 0.00%

SKIN - Free Cash Flow / Share

🔓 See the full chart40% off right now · 7-day free trial

SKIN Free Cash Flow / Share CAGR:1Y: -86.78%2Y: -42.02%5Y: 0.00%10Y: 0.00%

SKIN - Operating Income

🔓 See the full chart40% off right now · 7-day free trial

SKIN Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

SKIN - Gross Profit

🔓 See the full chart40% off right now · 7-day free trial

SKIN Gross Profit CAGR:1Y: 0.46%2Y: 9.78%5Y: 0.87%10Y: 0.00%

SKIN - Shares Outstanding

🔓 See the full chart40% off right now · 7-day free trial

SKIN Shares Outstanding CAGR:1Y: -7.62%2Y: -4.44%5Y: 7.14%10Y: 0.00%

SKIN - Share Buybacks

🔓 See the full chart40% off right now · 7-day free trial

SKIN Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

SKIN - Stock-Based Comp

🔓 See the full chart40% off right now · 7-day free trial

SKIN Stock-Based Comp CAGR:1Y: -45.46%2Y: -33.25%5Y: -3.77%10Y: 0.00%

SKIN - Expenses

🔓 See the full chart40% off right now · 7-day free trial

SKIN Expenses CAGR:1Y: 5.24%2Y: -23.11%5Y: -21.30%10Y: 0.00%

SKIN - Revenue vs Net Income

🔓 See the full chart40% off right now · 7-day free trial

SKIN - EPS vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

SKIN - EPS vs PE Ratio

🔓 See the full chart40% off right now · 7-day free trial

SKIN - FCF vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

SKIN - FCF vs Stock Based Comp

🔓 See the full chart40% off right now · 7-day free trial

SKIN - Cash & Debt

🔓 See the full chart40% off right now · 7-day free trial

SKIN - Revenue by Segment

🔓 See the full chart40% off right now · 7-day free trial

SKIN Revenue CAGR:1Y: -7.77%2Y: -10.78%5Y: 1.63%10Y: 0.00%

SKIN - Revenue by Region

🔓 See the full chart40% off right now · 7-day free trial

SKIN Revenue CAGR:1Y: -7.77%2Y: -10.78%5Y: 1.63%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

SKIN - REVENUE: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

SKIN Actual Revenue CAGR:1Y: -7.77%2Y: -10.78%5Y: 1.63%10Y: 0.00%

SKIN - EPS: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

SKIN Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

SKIN - NET INCOME: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

SKIN Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

SKIN - EBITDA: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

SKIN Actual EBITDA CAGR:1Y: -54.03%2Y: 7.62%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

SKIN - Net Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

SKIN Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

SKIN - Gross Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

SKIN Gross Profit Margin CAGR:1Y: 8.93%2Y: 23.05%5Y: -0.75%10Y: 0.00%

SKIN - Price to Earnings

🔓 See the full chart40% off right now · 7-day free trial

SKIN Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

SKIN - Price To Sales Ratio

🔓 See the full chart40% off right now · 7-day free trial

SKIN Price To Sales Ratio CAGR:1Y: -59.59%2Y: -29.62%5Y: -44.28%10Y: 0.00%

SKIN - Return on Capital Employed

🔓 See the full chart40% off right now · 7-day free trial

SKIN Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

SKIN - Return on Invested Capital

🔓 See the full chart40% off right now · 7-day free trial

SKIN Return on Invested Capital CAGR:1Y: 0.00%2Y: -57.35%5Y: 0.00%10Y: 0.00%

Projected Future Returns & Dividends for SKIN

Based on past 5.9-year performance, here are SKIN growth metrics:

Share price CAGR of +1.1%
Dividend CAGR of +0%

Using SKIN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	SKIN (DRIP)	SKIN - No DRIP
Current Price	$11.56	$11.56
Start Shares	865.05	865.05
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	865.05	865.05
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$11.56	$11.56
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - SKIN

NOTE: Above numbers are our estimate based on SKIN's Dividend and Price CAGR over past 5.9 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Company Info

SkinHealth Systems Inc. (SKIN) had its IPO on 2020-11-24, and is traded on NASDAQ stock exchange.

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.

SKIN website: https://www.skinhealthsystems.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

DCF Model — SKIN

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $11.56

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →